The Bright Future Behind Genomic Sequencing

06:15pm, Friday, 09'th Apr 2021
Recent advances in computer technology have lit a fuse under the genomic sequencing industry. And here's what investors need to know now.
FULGENT GENETIC (FLGT) closed at $85.24 in the latest trading session, marking a -0.42% move from the prior day.
A rebounding economy is a good time to thaw out your risk capital and start buying some high-risk stocks with long-term potential. The post 8 High-Risk Stocks to Buy That Are Worth Taking A Chance On
Shareholders could be big winners if the demand for COVID-19 testing lingers.
Investors seeking a multi-year growth opportunity should watch out for these three stocks.
Is (FLGT) Outperforming Other Medical Stocks This Year?
This coronavirus testing company has been booming, but is its hot streak about to end?
One group especially stands out.
Agreement leverages Fulgent's Next Generation Sequencing (“NGS”) capabilities for genomic sequencing to aid in ongoing research of SARS-CoV-2, the virus that causes COVID-19 Agreement leverages Fu
Despite tremendous growth, the stock is cheap based on at least one common Wall Street metric.
These two genetic testing companies have different approaches.
Is (FLGT) Outperforming Other Medical Stocks This Year?

Biotech Stocks: What Will 2021 Look Like?

06:00am, Friday, 12'th Mar 2021
2020 was a wild run for the biotech sector, with COVID-19 dominating the headlines. What will happen this year?
Thanks to a blowout fourth quarter, a Los Angeles-area diagnostic and genetics company saw its shares soar to an all-time high. Fulgent Genetics Inc.(NASDAQ:FLGT) hit nearly $190 during the first week
Fulgent Genetics' share price has collapsed as the short squeeze bubble has moved on.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE